Search Results - "McGillicuddy, John W"

Refine Results
  1. 1

    A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation by Gonzales, Haley M., McGillicuddy, John W., Rohan, Vinayak, Chandler, Jessica L., Nadig, Satish N., Dubay, Derek A., Taber, David J.

    Published in American journal of transplantation (01-08-2020)
    “…Tacrolimus (Tac) is widely used to prevent rejection and graft loss in solid organ transplantation. A limiting characteristic of Tac is the high intra and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Extracorporeal life support for severe acute respiratory distress syndrome in adults by Hemmila, Mark R, Rowe, Stephen A, Boules, Tamer N, Miskulin, Judiann, McGillicuddy, John W, Schuerer, Douglas J, Haft, Jonathan W, Swaniker, Fresca, Arbabi, Saman, Hirschl, Ronald B, Bartlett, Robert H

    Published in Annals of surgery (01-10-2004)
    “…Severe acute respiratory distress syndrome (ARDS) is associated with a high level of mortality. Extracorporeal life support (ECLS) during severe ARDS maintains…”
    Get full text
    Journal Article
  5. 5

    Review and Evaluation of mHealth Apps in Solid Organ Transplantation: Past, Present, and Future by Fleming, James N., Pollock, McLean D., Taber, David J., McGillicuddy, John W., Diamantidis, Clarissa J., Docherty, Sharron L., Chambers, Eileen T.

    Published in Transplantation direct (01-03-2022)
    “…With the rapid and widespread expansion of smartphone availability and usage, mobile health (mHealth) has become a viable multipurpose treatment medium for the…”
    Get full text
    Journal Article
  6. 6

    Improving the Perioperative Value of Care for Vulnerable Kidney Transplant Recipients by Taber, David J., PharmD, BCPS, Pilch, Nicole A., PharmD, MSCR, BCPS, McGillicuddy, John W., MD, Bratton, Charles F., MD, Lin, Angello, MD, Chavin, Kenneth D., MD, PhD, FACS, Baliga, Prabhakar K., MD, FACS

    “…Background The increased use of marginal donors, an aging recipient population, and Diagnosis-Related Group (DRG) cost restraints place significant pressures…”
    Get full text
    Journal Article
  7. 7

    New method of stent-facilitated arterial reconstruction for orthotopic mouse liver transplantation by Zhou, Shaotang, MD, PhD, Palanisamy, Arun P., PhD, McGillicuddy, John W., MD, Theruvath, Tom P., MD, PhD, Emre, Sukru H., MD, Chavin, Kenneth D., MD, PhD

    Published in The Journal of surgical research (01-03-2014)
    “…Abstract Background Arterialized orthotopic liver transplantation (OLT) in the mouse mimics human liver transplantation physiologically and clinically. The…”
    Get full text
    Journal Article
  8. 8

    The Concept of a Composite Perioperative Quality Index in Kidney Transplantation by Taber, David J., PharmD, BCPS, McGillicuddy, John W., MD, Bratton, Charles F., MD, Lin, Angello, MD, Chavin, Kenneth D., MD, PhD, FACS, Baliga, Prabhakar K., MD, FACS

    “…Background Public reporting of patient and graft outcomes in a national registry and close Centers for Medicare and Medicaid Services oversight has resulted in…”
    Get full text
    Journal Article
  9. 9

    Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial by McGillicuddy, John W., Chandler, Jessica L., Sox, Luke R., Taber, David J.

    Published in The Annals of pharmacotherapy (01-12-2020)
    “…Background: Medication nonadherence is a leading cause of late allograft loss in kidney transplantation (KT). Tacrolimus trough coefficient of variation (CV),…”
    Get full text
    Journal Article
  10. 10

    Significant hospitalization cost savings to the payer with a pharmacist‐led mobile health intervention to improve medication safety in kidney transplant recipients by Taber, David J., Fleming, James N., Su, Zemin, Mauldin, Patrick, McGillicuddy, John W, Posadas, Aurora, Gebregziabher, Mulugeta

    Published in American journal of transplantation (01-10-2021)
    “…This was an economic analysis of a 12‐month, parallel arm, randomized controlled trial in adult kidney recipients 6 to 36 months posttransplant (NCT03247322)…”
    Get full text
    Journal Article
  11. 11

    Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety: A Randomized Controlled Clinical Trial by Gonzales, Haley M, Fleming, James N, Gebregziabher, Mulugeta, Posadas-Salas, Maria Aurora, Su, Zemin, McGillicuddy, John W, Taber, David J

    “…Medication safety events are predominant contributors to suboptimal graft outcomes in kidney transplant recipients. The goal of this study was to examine the…”
    Get full text
    Journal Article
  12. 12

    Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching by Rohan, Vinayak S, Taber, David J, Moussa, Omar, Pilch, Nicole A, Denmark, Signe, Meadows, Holly B, McGillicuddy, John W, Chavin, Kenneth D, Baliga, Prabhakar K, Bratton, Charles F

    Published in Experimental and clinical transplantation (01-02-2017)
    “…Elevated panel reactive antibody levels have been traditionally associated with increased acute rejection rate and decreased long-term graft survival after…”
    Get full text
    Journal Article
  13. 13

    Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant Recipients by Taber, David J., Hirsch, Jason, Keys, Alison, Su, Zemin, McGillicuddy, John W.

    Published in Therapeutic drug monitoring (01-06-2021)
    “…High tacrolimus intrapatient variability (tac IPV) is associated with poor outcomes in kidney transplantation, including rejection, donor-specific antibodies,…”
    Get full text
    Journal Article
  14. 14

    Laparoscopic Liver Resection in the Treatment of Hepatocellular Carcinoma by Mittler, Jens, MD, McGillicuddy, John W., MD, Chavin, Kenneth D., MD, PhD

    Published in Clinics in liver disease (01-05-2011)
    “…Laparoscopic liver resection is an emerging technique in liver surgery. Although laparoscopy is well established for several abdominal procedures and is…”
    Get full text
    Journal Article
  15. 15

    Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients by Taber, David J, Pilch, Nicole A, McGillicuddy, John W, Mardis, Caitlin, Treiber, Frank, Fleming, James N

    Published in American journal of health-system pharmacy (18-07-2019)
    “…The development, testing, and preliminary validation of a technology-enabled, pharmacist-led intervention aimed at improving medication safety and outcomes in…”
    Get full text
    Journal Article
  16. 16

    Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation by Taber, David J, Su, Zemin, Fleming, James N, McGillicuddy, John W, Posadas-Salas, Maria A, Treiber, Frank A, Dubay, Derek, Srinivas, Titte R, Mauldin, Patrick D, Moran, William P, Baliga, Prabhakar K

    Published in Transplantation (01-12-2017)
    “…BACKGROUNDLow tacrolimus concentrations have been associated with higher risk of acute rejection, particularly within African-American (AA) kidney transplant…”
    Get full text
    Journal Article
  17. 17

    Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial by Fleming, James N, Gebregziabher, Mulugeta, Posadas, Aurora, Su, Zemin, McGillicuddy, John W, Taber, David J

    Published in American journal of health-system pharmacy (15-07-2021)
    “…Abstract Purpose Nonadherence is a leading cause of death-censored allograft loss in kidney transplant recipients. Strong associations have tied tacrolimus…”
    Get full text
    Journal Article
  18. 18

    A Critical Analysis of the Specific Pharmacist Interventions and Risk Assessments During the 12-Month TRANSAFE Rx Randomized Controlled Trial by Gonzales, Haley M., Fleming, James N., Gebregziabher, Mulugeta, Posadas Salas, Maria Aurora, McGillicuddy, John W., Taber, David J.

    Published in The Annals of pharmacotherapy (01-06-2022)
    “…Background Medication safety issues have detrimental implications on long-term outcomes in the high-risk kidney transplant (KTX) population. Medication errors,…”
    Get full text
    Journal Article
  19. 19

    Region 11 MELD Na exception prospective study by Fisher, Robert A, Heuman, Douglas M, Harper, Ann M, Behnke, Martha K, Smith, Alastair D, Russo, Mark W, Zacks, Steven, McGillicuddy, John W, Eason, James, Porayko, Michael K, Northup, Patrick, Marvin, Michael R, Hundley, Johnathan, Nair, Satheesh

    Published in Annals of hepatology (01-01-2012)
    “…Hyponatremia complicates cirrhosis and predicts short term mortality, including adverse outcomes before and after liver transplantation. From April 1, 2008,…”
    Get full text
    Journal Article
  20. 20

    Kidney transplant recipients' attitudes about using mobile health technology for managing and monitoring medication therapy by Browning, Robert B, McGillicuddy, John W, Treiber, Frank A, Taber, David J

    “…Abstract Objectives To assess smartphone ownership, use of mobile health (mHealth) applications, and willingness to use this technology to facilitate…”
    Get full text
    Journal Article